Team:EPF Lausanne/Calendar/16 September 2013

From 2013.igem.org

(Difference between revisions)
Line 1: Line 1:
{{Template:EPFL2013Header}}
{{Template:EPFL2013Header}}
 +
<font size = "4"> Sensing </font> <BR>
-
Sensing <BR>
+
''Sequencing of the hya promoter plasmid'' <BR>
 +
-I send the newly isolated and purified hya-containing plasmid for sequencing.
-
'''Seuqencing of the hya promoter plasmid''' <BR>
+
''Transformation''<BR>
-
I send the newly isolated and purified hya-containing plasmid for sequencing.
+
-Because the functional assays of the sensing module were inconclusive, I decided to do another transformation with the Plasmids that I had sent for sequencing and whose results showed that the promoters were really present, namely the cad-promoter and the constitutive promoter from iGEM.
 +
<BR><BR>
-
'''Transformation'''
+
<font size = "4"> Nanoparticles</font> <BR>
-
Because the functional assays of the sensing module were inconclusive, I decided to do another transformation with the Plasmids that I had sent for sequencing and whose results showed that the promoters were really present, namely the cad-promoter and the constitutive promoter from iGEM.
+
-
 
+
''MMP2 digestion assays'' <BR>
-
 
+
-
'''Nanoparticles'''
+
-
 
+
-
MMP2 digestion assays  
+
{{Template:EPFL2013Footer}}
{{Template:EPFL2013Footer}}

Revision as of 16:56, 3 October 2013

Taxi.Coli: Smart Drug Delivery iGEM EPFL

Header

Sensing

Sequencing of the hya promoter plasmid
-I send the newly isolated and purified hya-containing plasmid for sequencing.

Transformation
-Because the functional assays of the sensing module were inconclusive, I decided to do another transformation with the Plasmids that I had sent for sequencing and whose results showed that the promoters were really present, namely the cad-promoter and the constitutive promoter from iGEM.

Nanoparticles

MMP2 digestion assays